Brief: Aadi Bioscience Announces Financial Results For Third Quarter

Whitehawk Therapeutics

09/11/2022 15:04

Nov 9 (Reuters) - Aadi Bioscience Inc  AADI.O :
    * AADI BIOSCIENCE ANNOUNCES FINANCIAL RESULTS FOR THE THIRD
QUARTER OF 2022 AND PROVIDES CORPORATE UPDATE
    * Q3 SALES ROSE 24 PERCENT TO $4.2 MILLION
    * QTRLY LOSS PER SHARE $0.68
    * CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS AS OF
SEPTEMBER 30, 2022 WERE $183.0 MILLION
    * APPOINTMENT OF NEIL DESAI TO EXECUTIVE CHAIRMAN AND
TRANSITION
OF BRENDAN DELANEY TO CEO EFFECTIVE JANUARY 1, 2023
    * PRECISION 1 TRIAL ON-TRACK WITH PRELIMINARY DATA EXPECTED
IN
FIRST HALF OF 2023
    * Q3 EARNINGS PER SHARE VIEW $-0.74 -- REFINITIV IBES DATA
    * COMPLETED $72.5 MILLION PIPE FINANCING EXTENDING CASH
RUNWAY
INTO 2025

Source text for Eikon:  ID:nPnc4VNCGa 
Further company coverage:  AADI.O 
 ((reuters.briefs@thomsonreuters.com;))